Biomedical Engineering Reference
In-Depth Information
References
1. McKay IA. Growth factors: A practical approach. Oxford: IRL Press Ed, 1993.
2. Hubbell JA. Bioactive biomaterials. Curr Opin Biotechnol 1999; 10:123-9.
3. Dinbergs ID, Brown L, Edelman ER. Cellular response to transforming growth factor-beta1 and
basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J
Biol Chem 1996; 271:29822-9.
4. Centrella M, McCarthy TL, Canalis E. Transforming growth factor-beta and remodeling of bone.
J Bone Joint Surg Am 1991; 73:1418-28.
5. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGF beta
and BMP. Bone 1996; 19:1S-12S.
6. Mundy GR. Regulation of bone formation by bone morphogenetic proteins and other growth
factors. Clin Orthop 1996; 24-8.
7. Urist MR, Silverman BF, Buring K et al. The bone induction principle. Clin Orthop 1967;
53:243-83.
8. Zegzula HD, Buck DC, Brekke J et al. Bone formation with use of rhBMP-2 (recombinant hu-
man bone morphogenetic protein-2). J Bone Joint Surg Am 1997; 79:1778-90.
9. Cook SD, Salkeld SL, Brinker MR et al. Use of an osteoinductive biomaterial (rhOP-1) in healing
large segmental bone defects. J Orthop Trauma 1998; 12:407-12.
10. Gerhart TN, Kirker-Head CA, Kriz MJ. Healing segmental femoral defects in sheep using recom-
binant human bone morphogenetic protein. Clin Orthop 1993; 317-26.
11. Sandhu HS, Kanim LE, Kabo JM et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine
posterolateral (transverse process) spinal fusion model. Spine 1995; 20:2669-82.
12. Martin Jr GJ, Boden SD, Marone MA et al. Posterolateral intertransverse process spinal arthrodesis
with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and
safety. J Spinal Disord 1999; 12:179-86.
13. Boden SD, Martin Jr GJ, Morone MA et al. Posterolateral lumbar intertransverse process spine
arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite- tricalcium
phosphate after laminectomy in the nonhuman primate. Spine 1999; 24:1179-85.
14. Wozney JM. Overview of bone morphogenetic proteins. Spine 2002; 27:S2-8.
15. Boden SD, Andersson GB, Anderson DG et al. Summary statement: Overview of bone morphoge-
netic proteins for spine fusion. Spine 2002; 27:S1.
16. Syftestad GT, Triffitt JT, Urist MR et al. An osteo-inductive bone matrix extract stimulates the in
vitro conversion of mesenchyme into chondrocytes. Calcif Tissue Int 1984; 36:625-7.
17. Urist MR, Lietze A, Mizutani H et al. Finerman. A bovine low molecular weight bone morphoge-
netic protein (BMP) fraction. Clin Orthop 1982; 219-32.
18. Lucas PA, Syftestad GT, Goldberg VM et al. Ectopic induction of cartilage and bone by
water-soluble proteins from bovine bone using a collagenous delivery vehicle. J Biomed Mater Res
1989; 23:23-39.
19. Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J
Endocrinol 2000;142:9-21.
20. Wang EA, Rosen V, Cordes P et al. Purification and characterization of other distinct bone-inducing
factors. Proc Natl Acad Sci USA 1988; 85:9484-8.
21. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science 1983;
220:680-6.
22. Kuboki Y, Takita H, Kobayashi D et al. BMP-induced osteogenesis on the surface of hydroxyapa-
tite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J Biomed Mater
Res 1998; 39:190-199.
23. Jin QM, Takita H, Kohgo T et al. Effects of geometry of hydroxyapatite as a cell substratum in
BMP-induced ectopic bone formation. J Biomed Mater Res 2000; 51:491-499.
24. Ripamonti U, Ma S, Reddi AH. The critical role of geometry of porous hydroxyapatite delivery
system in induction of bone by osteogenin, a bone morphogenetic protein. Matrix 1992; 12:202-12.
25. Sampath TK, Reddi AH. Importance of geometry of the extracellular matrix in endochondral bone
differentiation. J Cell Biol 1984; 98:2192-7.
26. Ranade VV. Drug delivery systems: 3A. Role of polymers in drug delivery. J Clin Pharmacol 1990;
30:10-23.
27. Hollinger JO, Schmitz JP. Macrophysiologic roles of a delivery system for vulnerary factors needed
for bone regeneration. Ann NY Acad Sci 1997; 831:427-37.
28. Li RH, Wozney JM. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol
2001; 19:255-65.
29. Uludag H, D'Augusta D, Golden J et al. Wozney. Implantation of recombinant human bone
morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics
and osteoinduction in the rat ectopic model. J Biomed Mater Res 2000; 50:227-38.
Search WWH ::
Custom Search